Spots Global Cancer Trial Database for A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
Official Title: A Feasibility Study of Non-Invasive Cerenkov Luminescence Imaging in Patients With Cancer
Study ID: NCT03484884
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to test Cerenkov luminescence imaging, which is a different way to take pictures of thyroid cancer and/or any tumors with (existing or suspected) nodal metastases in the neck, supraclavicular, axillary and/or inguinal region.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Memorial Sloan - Kettering Cancer Center, New York, New York, United States
Contact Details
Name: Jan Grimm, MD, PhD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
